Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
SUTRO BIOPHARMA, INC. (STRO) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/09/2023 8-K Investor presentation
Docs: "2.5 2.3 2.4 2.6 2.3 2.5 2.5",
"Sutro Biopharma Announces Update from STRO-002, Luveltamab Tazevibulin , Phase 1 Dose-Expansion Study and Registrational Plans in Advanced Ovarian Cancer - Results from the STRO-002 Phase 1 dose-expansion study demonstrate that FolRα-selected patients experienced meaningful clinical benefit, with 43.8% ORR, median DOR of 5.4 months, and median PFS of 6.6 months at the higher starting dose of 5.2mg/kg - - Meaningful clinical benefit was observed in FolRα-selected patients, defined as TPS>25%, which is potentially 80% of the advanced ovarian cancer patient population - - Safety profile is generally consistent with prior data with asymptomatic neutropenia being the primary adverse event; no new safety signals were observed - - Use of prophylactic pegfilgrastim reduced dose delays ...",
"2.5 2.3 2.4 2.6 2.3 2.5 2.5"
06/27/2022 8-K Quarterly results
06/16/2022 8-K Quarterly results
01/10/2022 8-K Investor presentation
Docs: "2 3 4 3"
11/10/2021 8-K Investor presentation, Quarterly results
Docs: "Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones",
"Company Overview Presentation"
05/19/2021 8-K Quarterly results
09/09/2020 8-K Investor presentation
Docs: "Corporate Presentation",
"STRO-002 Interim Data Presentation"
06/15/2020 8-K Investor presentation
Docs: "Corporate Presentation"
10/29/2019 8-K Investor presentation
Docs: "Sutro Biopharma Presents Encouraging Preliminary Clinical Data in Ongoing Phase I Study for STRO-002 Antibody-Drug Conjugate in Patients with Advanced Ovarian Cancer",
"Presentation"
06/17/2019 8-K Investor presentation
Docs: "L 0.05 0.05 0.075 0.075 0.15 0.15 0.27 0.27 0.43 0.65 0.432 0.406 0.469 1.200 2.350 1.150 2.600 6.170 7.490 9.080 1.083 1.083 1.083 1.083 1.083 1.083 1.083 1.083 1.083 1.083 24 24 48 48 48 48 48 168 168 168 0.93 0.92 1.85 3.28 6.21 2.96 5.85 14.60 26.44"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy